Differential induction of antibody-dependent cellular cytotoxicity (ADCC) against human EGFR-expressing NSCLC cell lines by necitumumab, cetuximab, and panitumumab.
D. Patel
No relevant relationships to disclose
B. Saxena
No relevant relationships to disclose
Q. Zhou
No relevant relationships to disclose
W. Walton
No relevant relationships to disclose
R. Srikakulum
No relevant relationships to disclose
R. Manteiga
No relevant relationships to disclose
J. Haurum
No relevant relationships to disclose
J. R. Tonra
No relevant relationships to disclose
X. Kang
No relevant relationships to disclose